Suppr超能文献

高苯丙氨酸血症患者和苯丙酮尿症患者苯丙氨酸-4-羟化酶系统的体内研究。

In vivo studies of the phenylalanine-4-hydroxylase system in hyperphenylalaninemics and phenylketonurics.

作者信息

Curtius H C, Zagalak M J, Baerlocher K, Schaub J, Leimbacher W, Redweik U

出版信息

Helv Paediatr Acta. 1978 Feb;32(6):461-9.

PMID:632110
Abstract

An in vivo determination of the phenylalanine-4-hydroxylase (E. C. 1.14.16.1) activity is described. Subjects were loaded wit deuterated L-phenylalanine-d5 (200 mg/kg), and the deuterated tyrosine and deuterated phenylalanine in plasma was analyzed using mass fragmentography. Six phenylketonurics (PKU), four hyperphenylalaninemics and two healthy controls were investigated. This method allowed a specific differentiation between PKU's, hyperphenylalaninemics and health controls. The remaining enzyme activity in hyperphenylalaninemics and in PKU patients can be estimated with relatively high accuracy. The hyperphenylalaninemic patients showed 7--17% of the phenylalanine-4-hydroxylase activity found in the two control persons. The PKU patients under diet showed approximately 2--3% of the activity found in the control group. In the PKU patients, loaded while showing high phenylalanine blood concentrations, no remaining activity could be measured. The logarithm of phenylalanine-d5 over tyrosine-d4 in plasma 1 h after loading gives the best differentiation. One single plasma sample of approximately 0.5 ml is sufficient.

摘要

本文描述了一种苯丙氨酸-4-羟化酶(E.C.1.14.16.1)活性的体内测定方法。给受试者静脉注射氘代L-苯丙氨酸-d5(200mg/kg),并使用质量碎片分析法分析血浆中的氘代酪氨酸和氘代苯丙氨酸。研究了6名苯丙酮尿症患者(PKU)、4名高苯丙氨酸血症患者和2名健康对照者。该方法能够特异性地区分PKU患者、高苯丙氨酸血症患者和健康对照者。高苯丙氨酸血症患者和PKU患者剩余的酶活性能够得到相对准确的估计。高苯丙氨酸血症患者的苯丙氨酸-4-羟化酶活性为两名对照者的7%-17%。接受饮食治疗的PKU患者的活性约为对照组的2%-3%。对于血苯丙氨酸浓度较高时接受检测的PKU患者,未检测到剩余活性。负荷后1小时血浆中苯丙氨酸-d5与酪氨酸-d4的对数给出了最佳区分效果。约0.5ml的单个血浆样本就足够了。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验